Product

IASOdopa

iasodopa header

Marketing Authorizations

Country
Product Name
MA number
Date of registration
PDF
PDF
France
IASOdopa
578 256-2 (15mL) 566 897-8 (25mL)
16.11.2006
Austria
IASOdopa
4-00032
29.11.2007
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
Germany
IASOdopa
69747.00.00
31.08.2007
No data was found
No data was found
Italy
Fluorodopa IASON
038449031(20mL)/ 038449043 (11mL)
12.09.2013
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found

Product sheets

Name
Download
IASOdopa/Fluorodopa

6-fluoro-(¹⁸F)-L-dopa is indicated for use with positron emission tomography (PET) in adults and paediatric population.

Neurology

PET with 6-fluoro-(18F)-L-dopa is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum. It can be used for diagnosis of Parkinson’s disease and differentiation between essential tremor and parkinsonian syndromes.

Oncology

Among medical imaging modalities, PET with 6-fluoro-(18F)-L-dopa provides a functional approach of pathologies, organs or tissues where enhanced intracellular transport and decarboxylation of the amino acid dihydroxyphenylalanine is the diagnostic target. The following indications have been particularly documented:

Diagnosis

  • Diagnosis and localisation of focal hyperplasia of beta islet cells in the case of hyperinsulinism in infants and children
  • Diagnosis and localisation of paragangliomas in patients with a gene mutation of the succinate dehydrogenase D variant
  • Localisation of pheochromocytoma

Staging

  • Phaeochromocytoma and paraganglioma
  • Well differentiated neuroendocrine tumours of midgut.

Detection in case of reasonable suspicion of recurrences or residual disease

  • Primary brain tumours of all grades of differentiation.
  • Phaeochromocytoma and paraganglioma
  • Medullary thyroid cancer with elevated serum levels of calcitonin
  • Well differentiated neuroendocrine tumours of midgut
  • Other endocrine digestive tumours when somatostatin receptor scintigraphy is negativeThis medicinal product is for diagnostic use only. 

Therapeutic indications. This medicinal product is for diagnostic use only.

More innovative
products

01

Arrow Right

02

Arrow Right

04

Arrow Right

Do you want to know more about our products?

For inquiries please contact us, we will be happy to assist you!

Scroll to Top